Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 double-blind randomized study of Glasdegib versus placebo in myelofibrosis patients previously treated with ruxolitinib
2014-001048-40Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glasdegib in myelofibrosis (MF), sponsored by Pfizer. Started Jun 2014; status: completed.
02
Drugs
glasdegib
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on 2014-001048-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001048-40.